Author:
Exeli Ann-Katrin,Kellner Daniel,Exeli Lukas,Steininger Phil,Wolf Frank,Sedlmayer Felix,Deutschmann Heinz
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference37 articles.
1. Barani I, Larson D. Current understanding and treatment of glioblastoma. Cancer Treat Res. 2015;163:49–73.
2. Nachbichler SB, Schupp G, Ballhausen H, et al. Temozolomide during radiotherapy of glioblastoma multiforme. Strahlenther Onkol. 2017;193:1–7.
3. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–66.
4. Meyers C, Brown PD. Role and relevance of Neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol. 2006;24:1305–9.
5. Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy associated cognitive disability in patients with brain tumours. Neurol. 2016;185:52–64.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献